Shifa International HospitalsKAR:SHFA 85 ROE % is 13.51% as of Mar. 2026, which is 13% above its 10-year median of 11.93. GuruFocus rates KAR:SHFA with a GF Score™ of 85/100 and a GF Value™ of ₨453.79 (Modestly Overvalued). Among 625 Healthcare Providers & Services companies, Shifa International Hospitals ranks better than 79.52% on this metric.
The historical rank and industry rank for Shifa International Hospitals's ROE % or its related term are showing as below:
KAR:SHFA'
s ROE % Range Over the Past 10 Years
Min: 0.01 Med: 11.93 Max: 20.3
Current: 16.82
During the past 13 years, Shifa International Hospitals's highest ROE % was 20.30%. The lowest was 0.01%. And the median was 11.93%.
KAR:SHFA's ROE % is ranked better than 79.52% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs KAR:SHFA: 16.82
Shifa International Hospitals (KAR:SHFA) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Shifa International Hospitals ROE % Related Terms
Shifa International Hospitals ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Shifa International Hospitals's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shifa International Hospitals ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shifa International Hospitals's ROE % distribution charts can be found below:
* The bar in red indicates where Shifa International Hospitals's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Shifa International Hospitals (KAR:SHFA) has a ROE % of 13.51% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shifa International Hospitals and its competitors. This is 13% above median its historical median of 11.93. Over the past decade, Shifa International Hospitals' ROE % has ranged from 0.01 to 20.30. According to the industry distribution chart, Shifa International Hospitals ranks #128 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 20.5%.
Is Shifa International Hospitals' ROE % too high?
Shifa International Hospitals' current ROE % of 13.51% is 13% above median its 10-year median of 11.93. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 20.30. The Healthcare Providers & Services industry median ROE % is 5.84. Shifa International Hospitals' value of 13.51% is 131.3% above this industry median. Based on the distribution chart, Shifa International Hospitals ranks #128 out of 625 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Shifa International Hospitals has a GF Score™ of 85/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shifa International Hospitals' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shifa International Hospitals ranks #128 out of 625 companies for ROE %. This places Shifa International Hospitals in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 5.84. Shifa International Hospitals' value of 13.51% is 131.3% above this benchmark. Historically, Shifa International Hospitals' own ROE % has ranged from 0.01 to 20.30 over the past decade. While the company's 10-year median is 11.93 vs. the industry median of 5.84, Shifa International Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shifa International Hospitals's current ROE % of 13.51% is 131.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shifa International Hospitals and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shifa International Hospitals's current ROE % is 13.51%, which is 13% above median its own 10-year median of 11.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shifa International Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Shifa International Hospitals (KAR:SHFA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨453.79, compared to a current price of ₨520.98 — trading 14.8% above its estimated fair value. The current ROE % is 13.51%, which is 13% above median its 10-year median of 11.93 and 131.3% above the Healthcare Providers & Services industry median of 5.84. Shifa International Hospitals' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shifa International Hospitals (KAR:SHFA), the current ROE % is 13.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shifa International Hospitals (KAR:SHFA) Overvalued in 2026?
Based on GuruFocus' analysis, Shifa International Hospitals stock appears to be overvalued.
The current stock price of ₨520.98 is trading 14.8% above its estimated GF Value™ of ₨453.79.
GuruFocus considers Shifa International Hospitals to be Modestly Overvalued.
Key valuation signals for KAR:SHFA:
ROE %: 13.51% (13% above median its 10-year median of 11.93)
GF Value™: ₨453.79 vs. price of ₨520.98 (14.8% above fair value)
Industry Position: 131.3% above the Healthcare Providers & Services median (#128 of 625)
No single metric tells the full story. See the KAR:SHFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shifa International Hospitals Business Description
Shifa International Hospitals Ltd operates a network of medical centers and hospitals in Pakistan, providing a wide range of medical and surgical services across various specialties. The company offers organ transplant services, including liver, kidney, bone marrow, and corneal transplants. It generates revenue through patient care services, diagnostics, pharmacy operations, and support services such as emergency care and outpatient clinics. Shifa also operates lab collection points, day care surgeries, and diagnostic centers. The company has a presence in multiple cities through hospitals, medical centers, and subsidiaries that support healthcare services and infrastructure development.
85GF Score
Get the complete analysis for KAR:SHFA
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:SHFA has been successfully added to your 
